1. DHS/PP HIV/AIDS 2008 Update David H. Spach, MD Clinical Director, NWAETC Professor of Medicine Division of Infectious Diseases University of Washington, Seattle 2. HIV/AIDS…

Slide 1Lecture 4 Slide 2 Slide 3 Primary immune deficiency diseases. Lymphocyte development and sites of block in primary immune deficiency diseases. The affected genes are…

New strategy for the viral protein structure predictions: “Consensus model” approach to take advantage of sequence diversity Introduction The viral surface proteins are…

Slide 1 Announcements 1.Writing assignments due Friday November 2nd by 11am One digital copy per group to turnitin.com One hard copy per group to SW551 One ‘equal work-load…

Slide 1 Strategies for antiviral therapy The process targeted be essential for virus replication. That the therapeutic agent is active against the virus while having "acceptable…

Imke Steffen ZIB-Seminar 15. December 2008 Microbial “Anti-Immunology“ Highly effective mechanisms of pathogens to overcome both innate and acquired immunity Difficulties…

PowerPoint Presentation An integrated European effort to develop vaginal/rectal HIV preventive drugs Guido Vanham and Kevin Ariën, Virology Unit, Institute of Tropical Medicine,…

HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV Azidothymidine (Zidovudin(AZT))…

Imke Steffen ZIB-Seminar 15. December 2008 Microbial “Anti-Immunology“ Highly effective mechanisms of pathogens to overcome both innate and acquired immunity Difficulties…

Physical Biology of the Cell Hints to the Problems Rob Phillips, Jane Kondev, Julie A. Theriot and Hernan G. Garcia November 26, 2012 admin Text Box This is a draft version…